Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 4:28 AM ET

Biotechnology

Company Overview of Juno Therapeutics Inc.

Executive Profile

Mark W. Frohlich M.D.

Executive Vice President of Research & Development, Juno Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

53$2,049,667
As of Fiscal Year 2014

Background

Dr. Mark W. Frohlich, M.D. has been an Executive Vice President of Research & Development at Juno Therapeutics Inc. since February 2014. Dr. Frohlich has more than two decades of experience in the field of immuno-oncology. Dr. Frohlich served as the Chief Medical Officer of Dendreon Corp. since January 2008 until February 1, 2014 and as its Executive Vice President of Research and Development from March 2011 to February 1, 2014, where he led teams responsible for the ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

BS
Yale University
MD
Harvard Medical School
Post-Doctoral Training
University of California-San Francisco

Other Affiliations

Annual Compensation

Salary$366,667
Bonus$200,000
Total Annual Compensation$566,667

Stocks Options

Restricted Stock Awards$1,375,000

Total Compensation

Total Annual Cash Compensation$674,667
Total Short Term Compensation$566,667
Other Long Term Compensation$1,375,000
Total Calculated Compensation$2,049,667
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.